Helium thermocoagulation versus electrosurgery for endometriosis.

  • Research type

    Research Study

  • Full title

    Laparoscopic excision/ablation with Helium Thermal Coagulator compared with electro-diathermy for the treatment of mild to moderate endometriosis: a randomised controlled trial.

  • IRAS ID

    132906

  • Contact name

    Gourab Misra

  • Contact email

    gourab.misra@uhns.nhs.uk

  • Sponsor organisation

    University Hospital of North Midlands NHS Trust

  • Research summary

    Endometriosis is a condition where cells similar to those within the lining of the
    womb are found elsewhere in the body. It can be a chronic and painful
    condition for some women. Around 2 million women in the UK are affected by
    endometriosis. It is a long-term condition that causes painful or heavy periods
    and lower abdominal, pelvic or lower back pain. It may also lead to fertility
    problems.
    There is no known cure for endometriosis, although symptoms may be
    controlled by hormone treatments or painkillers. Women who do not respond
    may be offered minimally invasive (keyhole) surgery to remove the diseased
    tissue. This treatment is applied through a special tube called a laparoscope.
    The standard keyhole procedure to treat this condition is laparoscopic removal
    or burning of tissue with electrodiathermy (a procedure in which tissue is
    heated to destroy abnormal cells). This can have side effects such as
    inadvertent injury to the bowel or the urinary system. Therefore, we aim to test
    the efficacy of a relatively new treatment that involves the use of a helium
    beam thermo-coaugulator that has potentially fewer side-effects.
    This study aims to address this by running a trial that will directly compare 2
    different keyhole procedures; standard treatment (electrodiathermy) and
    helium thermal electro-coagulation. The team will assess the differences of the
    2 procedures on the relief of symptoms, intra and post-operative complications
    and quality of life for endometriosis sufferers. We will collect data from the
    patients before surgery and 6 weeks, 3 months and 9 months after surgery.
    The study team will use the data collected to inform patients and doctors of the
    best choice for endometriosis surgery that has the best symptom relief and
    fewer complications. The results will have implications for improving future
    patient care of endometriosis sufferers with mild-moderate disease.

  • REC name

    East Midlands - Leicester Central Research Ethics Committee

  • REC reference

    13/EM/0354

  • Date of REC Opinion

    18 Sep 2013

  • REC opinion

    Favourable Opinion